Bellicum Pharmaceuticals Garners $139,650,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ecf456e1-fd54-4d44-bb27-d39c5133e8c9
Date
12/19/2014
Company Name
Bellicum Pharmaceuticals
Mailing Address
2130 West Holcombe Boulevard Houston, TX 77030 USA
Company Description
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases.
Website
http://www.bellicum.com
Transaction Type
IPO
Transaction Amount
$139,650,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC.
M&A Terms